The U.S. wound and tissue management market was valued at $7.2 billion in 2011 and is forecasted to reach over $10.4 billion by 2018. Growth will be driven by advancements in antimicrobial and interactive dressings, as well as synthetic tissue sealant and anti-adhesion adoption. Research shows that the interactive dressings segment experienced over 20% growth in 2010 due to the success of Dermagraft®, a skin-substitute product from Shire. Companies are battling for control of this segment, which will be one of the fastest-growing in the industry as demand for skin-substitutes increases to treat chronic wounds and diabetic foot ulcers. Additionally, the antimicrobial dressings segment is expected to grow rapidly from the need to reduce facility acquired infections and combat drug-resistant bacteria.

For more information, read more about the wound and tissue managment market here.